VALANX
2 known investors
Find your way into VALANX
83 people in our graph share verified history with the VALANX team — schools, employers, funds. One of them is your warm intro.
David Kaufmanunlockedknows Klaus Orlinger · together at HOOKIPA Pharma Inc. (overlapped)
×9knows the team · via University of Vienna
×2knows the team · via Medical University of Vienna
VALANX Biotech develops a site-specific protein conjugation technology (GoldenSite) using click-chemistry to produce homogeneous antibody-drug conjugates with optimized conjugation sites. It targets biopharma developers building next-generation ADCs, aiming to widen therapeutic windows and reduce off-target toxicity.
Founders & leadership
ML
Michael LukeschinCEO & Founder
GA
Georg AltenbacherinCBO & Co-Founder
KO
Klaus OrlingerinChief Scientific OfficerHe has led R&D teams in pharmaceutical development, advancing drug candidates in immunooncology and infectious diseases through phase I/II trials, and previously helped build a biotech company from early stage through IPO.
Investors · 2
In the news
Frequently asked questions
- What does VALANX do?
- VALANX Biotech develops a site-specific protein conjugation technology (GoldenSite) using click-chemistry to produce homogeneous antibody-drug conjugates with optimized conjugation sites. It targets biopharma developers building next-generation ADCs, aiming to widen therapeutic windows and reduce off-target toxicity.
- Who founded VALANX?
- VALANX was founded by Michael Lukesch, Georg Altenbacher.
- Who are VALANX's investors?
- VALANX's investors include xista science ventures, SOSV.